Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03076346 · ClinicalTrials.gov registry record
Neural Biomarkers of Clozapine Response
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 41
- Enrollment target
NCT03076346 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 41 participants.
The verdict
NCT03076346 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 41 participants
- Enrollment target
Study Summary
Clozapine has consistently shown to be a superior drug for psychosis in patients who do not respond to other treatments, but its mechanism of action remains unknown. The overall goal of this study is to examine the functional neural circuitry that underlies successful treatment with clozapine, which may lead to the identification of biomarkers that will allow for more efficient use of clozapine, as well as additional treatment targets for patients with refractory illness.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2017-09-01 |
| Est. Completion | 2020-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03076346
The ClinicalTrials.gov registry entry for NCT03076346 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03076346 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03076346 about?
NCT03076346 is a clinical study titled "Neural Biomarkers of Clozapine Response". Clozapine has consistently shown to be a superior drug for psychosis in patients who do not respond to other treatments, but its mechanism of action remains unknown. The overall goal of this study is to examine the functional neural circuitry that underlies successful treatment with clozapine, which...
What is the current status of trial NCT03076346?
This trial is currently completed. The enrollment target is 41 participants. The study started on 2017-09-01. Estimated completion is 2020-12-31.
Who is sponsoring clinical trial NCT03076346?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.